YD Bio (YDES) Total Liabilities (2024 - 2026)
YD Bio's (YDES) quarterly Total Liabilities came in at $5.6 million in Q2 2026, up 641.94% year-over-year from $752935.0 in Q2 2025, and down 66.42% quarter-over-quarter from $16.6 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Total Liabilities (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Total Liabilities for 3 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities rose 641.94% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $5.6 million, a 641.94% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, down 93.93% from the prior year.
- Total Liabilities was $5.6 million for Q2 2026 at YD Bio, down from $16.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $274.0 million in Q4 2024 and troughed at $752935.0 in Q2 2025.
- A 3-year average of $74.2 million and a median of $11.1 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 93.93% in 2025 and surged 641.94% in 2026, its largest moves.
- Over 3 years, Total Liabilities stood at $274.0 million in 2024, then slumped by 93.93% to $16.6 million in 2025, then slumped by 66.42% to $5.6 million in 2026.
- The last three Total Liabilities figures came in at $5.6 million (Q2 2026), $16.6 million (Q4 2025), and $752935.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 83.95 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 37.53 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 7.18 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 10.02 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 4.20 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 1.62 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 13.24 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 384.62 Mn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - | 5.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.59 Mn |
| Dec 31, 2025 | 16.64 Mn |
| Jun 30, 2025 | 752,935.00 |
| Dec 31, 2024 | 273.98 Mn |
API Access
YD Bio Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();